GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » GRAIL Inc (NAS:GRAL) » Definitions » Future 3-5Y EPS without NRI Growth Rate

GRAIL (GRAL) Future 3-5Y EPS without NRI Growth Rate : 18.83 (As of May. 05, 2025)


View and export this data going back to 2024. Start your Free Trial

What is GRAIL Future 3-5Y EPS without NRI Growth Rate?

Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, GRAIL's Future 3-5Y EPS without NRI Growth Rate is 18.83.


Competitive Comparison of GRAIL's Future 3-5Y EPS without NRI Growth Rate

For the Diagnostics & Research subindustry, GRAIL's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


GRAIL's Future 3-5Y EPS without NRI Growth Rate Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, GRAIL's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where GRAIL's Future 3-5Y EPS without NRI Growth Rate falls into.


;
;

GRAIL  (NAS:GRAL) Future 3-5Y EPS without NRI Growth Rate Explanation

Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.


GRAIL Future 3-5Y EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of GRAIL's Future 3-5Y EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


GRAIL Business Description

Industry
Traded in Other Exchanges
Address
1525 O’Brien Drive, Menlo Park, CA, USA, 94025
GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages. It operates in one reportable operating segment which provides multi-cancer early detection testing and service.